Clinical evaluation of imipenemcilastatin in the therapy of severe infections in high risk patients.
Cristiano
P
P
Institute of Internal Medicine, 1st Medical School, Naples University, Italy.
Iovene
M R
MR
Morelli
G
G
Simioli
F
F
Lobello
R
R
Altucci
P
P
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D015377:Cilastatin / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D005260:Female; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008297:Male; D012449:Safety
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination